BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16765030)

  • 21. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pregabalin. A new treatment for neuropathic pain].
    López-Trigo J; Sancho Rieger J
    Neurologia; 2006 Mar; 21(2):96-103. PubMed ID: 16525916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin: dose-response relationship in generalized anxiety disorder.
    Boschen MJ
    Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE; Foster RH
    CNS Drugs; 2006; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.
    Both C; Kojda G; Lange-Asschenfeldt C
    Expert Rev Neurother; 2014 Jan; 14(1):29-38. PubMed ID: 24308277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin for the treatment of painful neuropathy.
    Sonnett TE; Setter SM; Campbell RK
    Expert Rev Neurother; 2006 Nov; 6(11):1629-35. PubMed ID: 17144773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
    Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
    Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
    Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
    Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregabalin (Lyrica)].
    Ide Y
    Masui; 2013 Jul; 62(7):808-13. PubMed ID: 23905403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin for the treatment of social anxiety disorder.
    Kawalec P; Cierniak A; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2015 Apr; 24(4):585-94. PubMed ID: 25361817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.
    Micó JA; Prieto R
    CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin for alcohol dependence: a critical review of the literature.
    Guglielmo R; Martinotti G; Clerici M; Janiri L
    Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):105-15. PubMed ID: 23205518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.